Investing.com - BIO-Key (NASDAQ: BKYI) reported second quarter EPS of $-0.160, $0.02 better than the analyst estimate of $-0.180. Revenue for the quarter came in at $1.9M versus the consensus estimate of $2.2M.
BIO-Key's stock price closed at $0.640. It is down -7.110% in the last 3 months and down -64.280% in the last 12 months.
BIO-Key saw positive EPS revisions and negative EPS revisions in the last 90 days. See BIO-Key's stock price’s past reactions to earnings here.
According to InvestingPro, BIO-Key's Financial Health score is "fair performance".
Check out BIO-Key's recent earnings performance, and BIO-Key's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar